Weil Company, Inc. United Therapeutics Corp Transaction History
Weil Company, Inc.
- $268 Million
- Q4 2024
A detailed history of Weil Company, Inc. transactions in United Therapeutics Corp stock. As of the latest transaction made, Weil Company, Inc. holds 1,272 shares of UTHR stock, worth $392,119. This represents 0.17% of its overall portfolio holdings.
Number of Shares
1,272
Previous 11,803
89.22%
Holding current value
$392,119
Previous $4.23 Million
89.41%
% of portfolio
0.17%
Previous 1.49%
Shares
16 transactions
Others Institutions Holding UTHR
# of Institutions
725Shares Held
40.2MCall Options Held
123KPut Options Held
104K-
Black Rock Inc. New York, NY5.47MShares$1.69 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.44MShares$1.37 Billion0.03% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.76MShares$851 Million14.19% of portfolio
-
State Street Corp Boston, MA2.2MShares$678 Million0.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.09MShares$644 Million1.16% of portfolio
About UNITED THERAPEUTICS Corp
- Ticker UTHR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,516,300
- Market Cap $14B
- Description
- United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...